Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy

BACKGROUND Serum brain-derived neurotrophic factor (BDNF) levels have been shown to be lower in patients with Chagas cardiomyopathy (ChC) than in patients with non-dilated chagasic cardiomyopathy. However, its prognostic value was not established in patients with ChC. METHODS Forty-nine patients w...

Full description

Bibliographic Details
Main Authors: Henrique S Costa, Marcia Maria O Lima, Pedro Henrique S Figueiredo, Patrícia M Martinelli, Elizabeth RS Camargos, Ana Thereza Chaves, Maria Carmo Pereira Nunes, Manoel Otavio C Rocha
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2018-08-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762018001000300&lng=en&tlng=en
_version_ 1797720703768723456
author Henrique S Costa
Marcia Maria O Lima
Pedro Henrique S Figueiredo
Patrícia M Martinelli
Elizabeth RS Camargos
Ana Thereza Chaves
Maria Carmo Pereira Nunes
Manoel Otavio C Rocha
author_facet Henrique S Costa
Marcia Maria O Lima
Pedro Henrique S Figueiredo
Patrícia M Martinelli
Elizabeth RS Camargos
Ana Thereza Chaves
Maria Carmo Pereira Nunes
Manoel Otavio C Rocha
author_sort Henrique S Costa
collection DOAJ
description BACKGROUND Serum brain-derived neurotrophic factor (BDNF) levels have been shown to be lower in patients with Chagas cardiomyopathy (ChC) than in patients with non-dilated chagasic cardiomyopathy. However, its prognostic value was not established in patients with ChC. METHODS Forty-nine patients with ChC (50 ± 7 years, New York Heart Association “NYHA” I-III); were evaluated by echocardiography, exercise testing, and blood analysis. Serum BDNF levels were determined using enzyme-linked immunosorbent assay sandwich. Patients were followed-up, and cardiac death was considered the end-point. The survival analyses were performed using Kaplan-Meier and Cox regression. RESULTS After 39 ± 14 months of follow-up, 12 patients (25%) died. The concentration of 2.5 ng/mL was the optimal cut-off value to predict survival with significant difference between the groups with low (≤ 2.5 ng/mL) and high (> 2.5 ng/mL) BDNF levels (p = 0.006). Lower serum BDNF levels (hazards ratio (HR) 1.1, 95% confidence interval (CI) 1.1-1.4; p = 0.001), peak oxygen uptake (HR 1.2, 95% CI 1.0-1.3; p = 0.009), and left ventricular ejection fraction (HR 0.8, 95% CI 0.7-0.9; p = 0.001) were the independent predictors of survival. The combination of low serum BDNF levels and reduced left ventricular ejection fraction were highly predictive of death (HR 5.6, 95% CI: 1.2-9.7; p = 0.026). CONCLUSION In patients with ChC, reduced serum BDNF levels, especially if associated with systolic function, may provide useful prognostic information.
first_indexed 2024-03-12T09:24:18Z
format Article
id doaj.art-7c588c5ad1e64f5697546c01a02996d4
institution Directory Open Access Journal
issn 1678-8060
language English
last_indexed 2024-03-12T09:24:18Z
publishDate 2018-08-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-7c588c5ad1e64f5697546c01a02996d42023-09-02T14:21:15ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz1678-80602018-08-011131010.1590/0074-02760180224S0074-02762018001000300Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathyHenrique S CostaMarcia Maria O LimaPedro Henrique S FigueiredoPatrícia M MartinelliElizabeth RS CamargosAna Thereza ChavesMaria Carmo Pereira NunesManoel Otavio C RochaBACKGROUND Serum brain-derived neurotrophic factor (BDNF) levels have been shown to be lower in patients with Chagas cardiomyopathy (ChC) than in patients with non-dilated chagasic cardiomyopathy. However, its prognostic value was not established in patients with ChC. METHODS Forty-nine patients with ChC (50 ± 7 years, New York Heart Association “NYHA” I-III); were evaluated by echocardiography, exercise testing, and blood analysis. Serum BDNF levels were determined using enzyme-linked immunosorbent assay sandwich. Patients were followed-up, and cardiac death was considered the end-point. The survival analyses were performed using Kaplan-Meier and Cox regression. RESULTS After 39 ± 14 months of follow-up, 12 patients (25%) died. The concentration of 2.5 ng/mL was the optimal cut-off value to predict survival with significant difference between the groups with low (≤ 2.5 ng/mL) and high (> 2.5 ng/mL) BDNF levels (p = 0.006). Lower serum BDNF levels (hazards ratio (HR) 1.1, 95% confidence interval (CI) 1.1-1.4; p = 0.001), peak oxygen uptake (HR 1.2, 95% CI 1.0-1.3; p = 0.009), and left ventricular ejection fraction (HR 0.8, 95% CI 0.7-0.9; p = 0.001) were the independent predictors of survival. The combination of low serum BDNF levels and reduced left ventricular ejection fraction were highly predictive of death (HR 5.6, 95% CI: 1.2-9.7; p = 0.026). CONCLUSION In patients with ChC, reduced serum BDNF levels, especially if associated with systolic function, may provide useful prognostic information.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762018001000300&lng=en&tlng=enbrain-derived neurotrophic factorChagas cardiomyopathyechocardiogramexercise testingprognosis
spellingShingle Henrique S Costa
Marcia Maria O Lima
Pedro Henrique S Figueiredo
Patrícia M Martinelli
Elizabeth RS Camargos
Ana Thereza Chaves
Maria Carmo Pereira Nunes
Manoel Otavio C Rocha
Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
Memorias do Instituto Oswaldo Cruz
brain-derived neurotrophic factor
Chagas cardiomyopathy
echocardiogram
exercise testing
prognosis
title Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
title_full Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
title_fullStr Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
title_full_unstemmed Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
title_short Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
title_sort prognostic value of serum brain derived neurotrophic factor levels in patients with chagas cardiomyopathy
topic brain-derived neurotrophic factor
Chagas cardiomyopathy
echocardiogram
exercise testing
prognosis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762018001000300&lng=en&tlng=en
work_keys_str_mv AT henriquescosta prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT marciamariaolima prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT pedrohenriquesfigueiredo prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT patriciammartinelli prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT elizabethrscamargos prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT anatherezachaves prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT mariacarmopereiranunes prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy
AT manoelotaviocrocha prognosticvalueofserumbrainderivedneurotrophicfactorlevelsinpatientswithchagascardiomyopathy